TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
Home›13F Funds›Viking Global
13F portfolio · as of 2026-03-31 (Q1 2026) · filed 2026-05-15

Viking Global

Tiger-lineage long/short with a fundamental, low-drama book.

Reported book
$35.7B
Positions
77
Vs prior quarter
20 new · 15 exited

Holdings

Viking Global latest 13F holdings with our verdicts
#HoldingOur call% of bookValueSharesQoQ
1VVisa Inc. Class AHold5.4%$1.91B6.33MAdded+59%
2TSMTaiwan Semiconductor ManufacturingSell4.2%$1.51B4.47MTrimmed-9%
3SCHWCharles Schwab CorpBuy3.9%$1.38B14.7MAdded+6%
4DISWalt Disney CompanyHold3.6%$1.28B13.3MAdded+19%
5FTVFortive CorpHold3.5%$1.24B22.5MAdded+17%
6APDAir Products and Chemicals IncHold3.3%$1.19B4.10MTrimmed-14%
7MCDMcDonald’s CorporationHold3.2%$1.13B3.63M—
8SHWSherwin-Williams CoHold2.8%$998M3.11MTrimmed-2%
9TSLATesla IncSell2.6%$927M2.49MAdded+47%
10AAPLApple Inc.Hold2.6%$912M3.59MNEW
11BBIOBridgeBio Pharma IncHold2.5%$879M11.8MTrimmed-18%
12CVNACarvana CoBuy2.4%$874M2.78MAdded+162%
13MSFTMicrosoft CorporationBuy2.4%$855M2.31MTrimmed-28%
14TMOThermo Fisher Scientific IncHold2.3%$820M1.67MAdded+110%
15JPMJPMorgan Chase & CoHold2.2%$795M2.70MAdded+42%
16CSXCSX CorporationSell2.1%$767M18.7MAdded+35%
17ICEIntercontinental Exchange IncBuy2.1%$761M4.84M—
18LIILennox International IncHold2.0%$730M1.57MAdded+153%
19GOOGLAlphabet Inc Class ABuy1.9%$689M2.40MTrimmed-10%
20FDXFedEx CorporationHold1.9%$688M1.93MNEW
21GMGeneral Motors CompanyBuy1.9%$684M9.18MAdded+35%
22BAThe Boeing CompanyHold1.8%$636M3.20MTrimmed-19%
23PNCPNC Financial Services Group IncBuy1.8%$630M3.03MTrimmed-58%
24TMUST-Mobile US IncHold1.7%$623M2.97MTrimmed-21%
25METAMeta Platforms Inc.Buy1.7%$608M1.06MNEW
26RRXRegal Beloit CorporationHold1.6%$589M3.14MTrimmed-3%
27MAAMid-America Apartment Communities IncHold1.6%$586M4.80MAdded+24%
28JCIJohnson Controls International PLCHold1.6%$579M4.42MTrimmed-25%
29MDLNMedline Inc. Class A Common StockHold1.4%$509M11.4MAdded+64%
30HCAHCA Healthcare, Inc.Buy1.4%$509M1.08MAdded+8%
31ATIAllegheny Technologies IncorporatedHold1.4%$485M3.33MNEW
32CLSCelestica Inc.Hold1.3%$466M1.65MTrimmed-3%
33CPTCamden Property TrustHold1.3%$461M4.72MTrimmed-1%
34CBChubb LtdBuy1.2%$422M1.30MAdded+28%
35ADPTAdaptive Biotechnologies CorpHold1.2%$416M30.0M—
36BMRNBiomarin Pharmaceutical IncBuy1.1%$399M7.06MAdded+17%
37SESea LtdBuy1.1%$392M4.74MAdded+29%
38WATWaters CorporationHold1.0%$374M1.26MNEW
39CARNIVAL CORP—1.0%$355M13.7MTrimmed-2%
40AONAon PLCHold1.0%$351M1.09MAdded+39%
41HASHasbro IncHold1.0%$350M3.74MNEW
42RDDTReddit, Inc.Buy1.0%$344M2.55MNEW
43PROGRESSIVE CORP—0.9%$320M1.62MAdded+21%
44AIGAmerican International Group IncHold0.9%$318M4.22MNEW
45COFCapital One Financial CorporationBuy0.8%$294M1.61MTrimmed-45%
46DKSDick’s Sporting Goods IncHold0.7%$251M1.26MTrimmed-51%
47AMZNAmazon.com IncBuy0.7%$249M1.20MTrimmed-62%
48ASAmer Sports, Inc.—0.7%$239M7.27MAdded+51%
49API GROUP CORP—0.7%$237M5.84MTrimmed-49%
50TICAcuren CorporationHold0.7%$236M35.8MAdded+4%
51CBOECboe Global Markets IncBuy0.5%$193M688KNEW
52ROIVRoivant Sciences LtdHold0.5%$184M6.65MAdded+3%
53HDThe Home Depot IncHold0.5%$166M504KNEW
54AJGArthur J Gallagher & CoHold0.4%$158M727KTrimmed-30%
55LULULululemon Athletica Inc.Buy0.4%$150M981KNEW
56NAMSNewAmsterdam Pharma Company N.V. Ordinary SharesHold0.4%$135M4.20M—
57ORKAOruka Therapeutics, Inc.Avoid0.4%$131M2.67M—
58SIONSionna Therapeutics, Inc. Common StockAvoid0.4%$128M3.20M—
59STLAStellantis NVSell0.3%$112M16.0MTrimmed-59%
60CRWVCoreWeave, Inc. Class A Common StockHold0.3%$108M1.40MNEW
61MANEVeradermics, IncorporatedAvoid0.3%$107M1.69MNEW
62WSTWest Pharmaceutical Services IncSell0.3%$105M417KAdded+41%
63PHVSPharvaris BV—0.3%$103M3.65M—
64INBXInhibrx Biosciences, Inc.Avoid0.3%$96.7M1.44M—
65IBKRInteractive Brokers Group IncHold0.3%$93.5M1.39MNEW
66RALRalliant Corporation Common StockHold0.2%$88.8M2.13MTrimmed-32%
67EWEdwards Lifesciences CorpHold0.2%$87.9M1.10MNEW
68ORIC PHARMACEUTICALS INC—0.2%$73.8M5.82MTrimmed-11%
69DMRADamora Therapeutics, Inc.Avoid0.2%$59.9M2.31MNEW
70TWLOTwilio IncHold0.2%$56.7M451KNEW
71LABStandard Biotools IncHold0.2%$53.9M58.7M—
72TRVITrevi Therapeutics IncHold0.1%$38.2M3.20M—
73GINKGO BIOWORKS HOLDINGS INC—0.1%$21.9M3.58M—
74EQPTEquipmentShare.com Inc Class A Common StockHold0.1%$20.4M1.00MNEW
75FPSForgent Power Solutions, Inc.—0.1%$19.0M650KNEW
76PEPGPepGen LtdAvoid0.0%$6.16M3.48M—
77RLYBRallybio CorpSell0.0%$4.70M524KNEW

Exited since Q4 2025

  • AMDwas $801M
  • DKNGwas $659M
  • ROSTwas $571M
  • CHWYwas $447M
  • UBSwas $426M
  • UNHwas $395M
  • SAIAwas $355M
  • TWwas $298M
  • BACwas $247M
  • BSXwas $239M
  • DLRwas $233M
  • LOWwas $220M
  • FIGwas $215M
  • ITUBwas $203M
  • RIOTwas $157M

Source: SEC Form 13F-HR. Positions are as-of quarter end (filed up to 45 days later) and cover US-listed equities only — shorts, non-US listings and most derivatives don’t appear. Values as reported by the filer. “Our call” is TENK/calls’s independent SEC-grounded verdict, not the fund’s view.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.